Recent Quotes (30 days)

You have no recent quotes
chg | %

Premaitha Health PLC news

   Watch this stock
Showing stories 1 - 10 of about 82   

Articles published

NIPT 7.66 -0.34 (-4.19%)
price chart
Premaitha Health
Premaitha uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA uses complex statistical analyses to determine the likelihood that a fetus is carrying... hardman & co. Premaitha Health PLC. Premaitha ...
Premaitha Health PLC (NIPT) PT Lowered to GBX 18 at FinnCap
Premaitha Health PLC logo Premaitha Health PLC (LON:NIPT) had its price objective trimmed by FinnCap from GBX 20 ($0.25) to GBX 18 ($0.22) in a report published on Wednesday.
Premaitha Health PLC 102.7% Potential Upside Indicated by finnCap
Premaitha Health PLC using EPIC/TICKER code LON:NIPT had its stock rating noted as 'Reiterates' with the recommendation being set at 'CORPORATE' today by analysts at finnCap.
Premaitha Health PLC (NIPT) Given New GBX 18 Price Target at FinnCap  Community Financial News
Premaitha welcomes government decision on prenatal tests
Premaitha Health PLC (LON:NIPT) has welcomed a decision by the UK Department of Health to make non-invasive prenatal tests (NIPTs) routinely available on the NHS to high risk pregnant women across the UK.
Premaitha Health to join AIM as it prepares to launch first product
Subject to ViaLogy shareholders approval later this month, the enlarged business will be re-named Premaitha Health PLC and will become a listed company on the AIM platform.
ViaLogy Buys Molecular Diagnostic Company  London South East
Related articles »  
Weekly Broker Update – Premaitha Health (LON:NIPT)
Premaitha Health PLC is engaged in molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for pre-natal screening and other clinical applications in the early detection, monitoring and ...
Premaitha Health PLC Premaitha Health signs Investment Agreement with Thermo ...
Premaitha's CE-marked, non-invasive prenatal screening (NIPT) product, the IONA� test, runs on Thermo Fisher's two sequencing instruments, the Ion Proton and Ion Chef.
FinnCap Reaffirms Corporate Rating for Premaitha Health PLC (NIPT)
Premaitha Health PLC logo FinnCap reiterated their corporate rating on shares of Premaitha Health PLC (LON:NIPT) in a research note released on Tuesday.
The Premaitha Health PLC (NIPT) PT Decreased to GBX 18
Premaitha Health PLC (LON:NIPT) had its target price reduced by FinnCap from GBX 20 ($0.25) to GBX 18 ($0.22) in a report released on Wednesday morning.
Premaitha Health (LON:NIPT) Broker Roundup  The De Soto Edge
Premaitha Health PLC (NIPT) Rating Reiterated by FinnCap
Premaitha Health PLC logo Premaitha Health PLC (LON:NIPT)'s stock had its “corporate” rating restated by research analysts at FinnCap in a research note issued on Monday.